Advertisement
Organisation › Details
Viatris (Group)
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life’s moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. *
Start | 2020-11-01 merged | |
Today | Viatris Inc. (Nasdaq: VTRS) | |
Predecessor | Mylan (Group) | |
Industry | pharmaceutical | |
Industry 2 | drug development | |
Region | Pittsburgh, PA | |
Country | United States (USA) | |
Street | 1000 Mylan Boulevard | |
City | 15317 Canonsburg, PA | |
Tel | +1-724-514-1800 | |
Address record changed: 2024-04-03 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil. | ||
Record changed: 2024-04-03 |
Advertisement
More documents for Viatris (Group)
- [1] Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil....
- [2] Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil....
- [3] Viatris Inc.. (2/28/24). "Press Release: Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance". Pittsburgh, PA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top